Comparative Efficacy And Side Effects Of Alemtuzumab Versus Basiliximab As Induction Agent In Lung Transplantation

被引：0
|
作者：
Kolman, D. [1 ]
Shapiro, W. [1 ]
Zhao, H. [1 ]
Butler-LeBair, M. [1 ]
Patel, N. [1 ]
Shiose, A. [1 ]
Toyoda, Y. [1 ]
Criner, G. J. [1 ]
Cordova, F. C. [1 ]
机构：
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5168
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation.
    Choe, J.
    Au, J.
    Diamond, A.
    Ruggia-Check, C.
    Sehgal, S.
    Cordova, F.
    Shigemura, N.
    Keshavamurthy, S.
    Toyoda, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1011 - 1012
  • [2] Evaluation of alemtuzumab versus basiliximab induction in lung transplantation
    Whited, Laura
    Latran, Mike
    Hage, Chadi
    Duncan, Michael
    Wang, I-Wen
    Roe, David
    Wozniak, Thomas
    PHARMACOTHERAPY, 2013, 33 (10): : E239 - E240
  • [3] Basiliximab versus Alemtuzumab: The Association Between Induction Agent and Airway Complications Following Lung Transplantation
    Furukawa, M.
    Chan, E. G.
    Harano, T.
    Ryan, J.
    Rivosecchi, R.
    Morrell, M. R.
    Sanchez, P. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 394 - 394
  • [4] The Impact Of Alemtuzumab And Basiliximab Induction On The Incidence Of Chronic Rejection In Lung Transplantation
    Furuya, Y.
    Kolman, D.
    Jayarajan, S.
    Patel, N.
    Toyoda, Y.
    Criner, G. J.
    Cordova, F. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Alemtuzumab Induction in Lung Transplantation: Efficacy and Safety
    Jaksch, P.
    Scheed, A.
    Zweytick, B.
    Ernst, M.
    Augustin, V.
    Klepetko, W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S67 - S67
  • [6] Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction
    Mietz, S.
    Roe, D.
    Lushin, E.
    Anderson, E.
    Hage, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1018 - 1018
  • [7] Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients
    Whited, Laura K.
    Latran, Michael J.
    Hashmi, Zubair A.
    Wang, I-Wen
    Wozniak, Thomas C.
    Duncan, Michael D.
    Roe, David W.
    Baz, Maher A.
    Hage, Chadi A.
    TRANSPLANTATION, 2015, 99 (10) : 2190 - 2195
  • [8] Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
    Furukawa, Masashi
    Chan, Ernest G.
    Ryan, John P.
    Hyzny, Eric J.
    Sacha, Lauren M.
    Coster, Jenalee N.
    Pilewski, Joseph M.
    Lendermon, Elizabeth A.
    Kilaru, Silpa D.
    McDyer, John F.
    Sanchez, Pablo G.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] ALEMTUZUMAB OR BASILIXIMAB AS ANTIBODY INDUCTION FOR SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION
    Kansal, Nisheeth
    Wilson, Colin
    French, Jeremy
    Jacques, Bryan
    Manas, Derek
    White, Steve
    TRANSPLANT INTERNATIONAL, 2013, 26 : 43 - 43
  • [10] A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation
    Magliocca, Joseph
    Odorico, Jon
    Pirsch, John
    Becker, Yolanda
    Knechtle, Stuart
    Leverson, Glen
    Sollinger, Hans
    XENOTRANSPLANTATION, 2007, 14 (05) : 381 - 382
12345